Ashatherapeutics
1 known investors
Asha Therapeutics uses physics-based computational methods to design drug molecules, operating at the intersection of computational chemistry and drug discovery. The company's approach aims to reduce time and cost in early-stage pharmaceutical development.
Founders & leadership
SS
Sam ShrivastavaFounder & Chief Executive Officer
BH
Bradlee Heckmann, Ph.D.President & Chief Scientific Officer | Scientific Co-Founder
RM
Rainer Metcalf, Ph.D.Chief Technology Officer | Scientific Co-Founder
Investors Β· 1
Frequently asked questions
- What does Ashatherapeutics do?
- Asha Therapeutics uses physics-based computational methods to design drug molecules, operating at the intersection of computational chemistry and drug discovery. The company's approach aims to reduce time and cost in early-stage pharmaceutical development.
- Who founded Ashatherapeutics?
- Ashatherapeutics was founded by Sam Shrivastava, Bradlee Heckmann, Ph.D., Rainer Metcalf, Ph.D..
- Who are Ashatherapeutics's investors?
- Ashatherapeutics's investors include ATP.